Your search returned 14 results.

Results
	1.	A Phase 1, Randomized, Single-Dose Crossover Pharmacokinetic Study to Investigate the Effect of Food Intake on Absorption of Orteronel (TAK-700) in Healthy Male Subjects. [electronic resource] by Suri, Ajit Pham, Theresa MacLean, David B Producer: 20180116 In: Clinical pharmacology in drug development vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study. [electronic resource] by Suri, Ajit Pusalkar, Sandeepraj Li, Yuexian Prakash, Shimoga Producer: 20180116 In: Clinical pharmacology in drug development vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Assessment of cytochrome P450-mediated drug-drug interaction potential of orteronel and exposure changes in patients with renal impairment using physiologically based pharmacokinetic modeling and simulation. [electronic resource] by Lu, Chuang Suri, Ajit Shyu, Wen Chyi Prakash, Shimoga Producer: 20150807 In: Biopharmaceutics & drug disposition vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Sustained exposure to the investigational Kisspeptin analog, TAK-448, down-regulates testosterone into the castration range in healthy males and in patients with prostate cancer: results from two phase 1 studies. [electronic resource] by MacLean, David B Matsui, Hisanori Suri, Ajit Neuwirth, Rachel Colombel, Marc Producer: 20141027 In: The Journal of clinical endocrinology and metabolism vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Population PK and Exposure-Response Relationships for the Antibody-Drug Conjugate Brentuximab Vedotin in CTCL Patients in the Phase III ALCANZA Study. [electronic resource] by Suri, Ajit Mould, Diane R Liu, Yi Jang, Graham Venkatakrishnan, Karthik Producer: 20190924 In: Clinical pharmacology and therapeutics vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology. [electronic resource] by Ji, Yan Jin, Jin Y Hyman, David M Kim, Geoffrey Suri, Ajit Producer: 20190715 In: Clinical and translational science vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures. [electronic resource] by Rosenstock, Julio Nakano, Masako Silverman, Bernard L Sun, Bin de la Peña, Amparo Suri, Ajit Muchmore, Douglas B Producer: 20070320 In: Diabetes technology & therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment. [electronic resource] by Suzuki, Yasuhiro Tokuda, Yutaka Fujiwara, Yasuhiro Iwata, Hiroji Sasaki, Yasutsuna Saji, Shigehira Aogi, Kenjiro Nambu, Yoshihiro Suri, Ajit Saeki, Toshiaki Takashima, Shigemitsu Producer: 20091112 In: Japanese journal of clinical oncology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. [electronic resource] by Yokoi, Fuji Gründer, Gerhard Biziere, Kathleen Stephane, Massoud Dogan, Ahmet S Dannals, Robert F Ravert, Hayden Suri, Ajit Bramer, Steven Wong, Dean F Producer: 20020807 In: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer. [electronic resource] by Clarke, Stephen J Boyer, Michael J Millward, Michael Underhill, Craig Moylan, Eugene Yip, Desmond White, Shane Childs, Annabel Beale, Phillip Latz, Jane Suri, Ajit Iglesias, Jose L Producer: 20060223 In: Lung cancer (Amsterdam, Netherlands) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Phase 1/2 study of orteronel (TAK-700), an investigational 17,20-lyase inhibitor, with docetaxel-prednisone in metastatic castration-resistant prostate cancer. [electronic resource] by Petrylak, Daniel P Gandhi, Jitendra G Clark, William R Heath, Elisabeth Lin, Jianqing Oh, William K Agus, David B Carthon, Bradley Moran, Susan Kong, Ning Suri, Ajit Bargfrede, Michael Liu, Glenn Producer: 20160119 In: Investigational new drugs vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer. [electronic resource] by Dreicer, Robert MacLean, David Suri, Ajit Stadler, Walter M Shevrin, Daniel Hart, Lowell MacVicar, Gary R Hamid, Omid Hainsworth, John Gross, Mitchell E Shi, Yuanjun Webb, Iain J Agus, David B Producer: 20141028 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors. [electronic resource] by Dy, Grace K Suri, Ajit Reid, Joel M Sloan, Jeff A Pitot, Henry C Alberts, Steven R Goldberg, Richard M Atherton, Pamela J Hanson, Lorelei J Burch, Patrick A Rubin, Joseph Erlichman, Charles Adjei, Alex A Producer: 20050621 In: Cancer chemotherapy and pharmacology vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. [electronic resource] by Locatelli, Franco Mauz-Koerholz, Christine Neville, Kathleen Llort, Anna Beishuizen, Auke Daw, Stephen Pillon, Marta Aladjidi, Nathalie Klingebiel, Thomas Landman-Parker, Judith Medina-Sanson, Aurora August, Keith Sachs, Jessica Hoffman, Kristen Kinley, Judith Song, Sam Song, Gregory Zhang, Stephen Suri, Ajit Gore, Lia Producer: 20181122 In: The Lancet. Haematology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)